Table 2. M. tb strains used in this study.
M. tb strain | Description | Expression | Reference | |
DevR Aer Hyp | DevRN-Kan Aer Hyp | |||
H37Rv | WT | + +++ | −− | [13] |
Mut1 | devRΔCTD, expresses DevRN-Kan protein from its native location (fusion gene created by in-frame insertion of promoterless kanamycin resistance cassette at the PpuMI site within devR gene), includes entire N-terminal signaling domain of DevR [residues 1–145], Kanr | −− | + ++ +++ | [13], this study |
Mut2 | Complete ΔdevR deletion | − − | − − | [12] |
Comp1 | M. tb Mut1 complemented with plasmid pDSDevR, Kanr, Hygr | + ↓ | +++ +++ | [13] |
Comp2 | M. tb Mut2 complemented with pDSDevR, Kanr, Hygr | + ↓ | −− | This study |
Comp3 | H37Rv containing pAVDevRN-Kan, Kanr, Hygr | + ++ | + + + +++ | This study |
Comp4 | M. tb Comp2 containing pAVDevRN-Kan, Kanr, Hygr | + ↓ | +++ +++ | This study |
Aer, aerobic; Hyp, hypoxic.
+, ++ etc., relative levels of DevR and DevRN-Kan proteins (semi- quantitative).
−, absence of DevR.
↓, decline in hypoxic level.